360head Stockiq
Global Intelligence Terminal
Loading live prices…
LIVE
--:--:--
AI-generated, informational and educational only. Not financial advice. Past performance does not indicate future results. Always do your own research.

Amgen Inc (AMGN)

A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.

Biotechnology· US· www.amgen.com
Trade AMGN on Webull →
28/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)50%

Also measured against its sector ETF (XBI).

Our last 30 days of resolved calls came true 18% of the time.See the track record →

Price
$465.67
1 day
-0.30%
1 week
+1.44%
Month to date
+0.23%
1 year
+38.89%
Market cap
$251.9B
Company fundamentals
P/E (TTM)
26.8×
EPS (TTM)
$17.25
Debt / Equity
3.76
Current ratio
1.48
Operating margin
32.6%
Net margin
24.1%
Gross margin
74.7%
Return on equity
85.6%
Revenue growth (YoY)
8.2%
Dividend yield
3.21%

Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.

Example trade plan · illustrative risk framework
Entry zone
$458.68–$474.98
Stop-loss (exit)
$419.10 −10%
Target (exit)
$558.80 +20%

A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.

Why it ranks: factor attribution

Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →

Why it's moving: recent catalysts

🤖 The dominant catalyst is product/pipeline news, centered on the Phase III success for Amgen's acquired Sjögren's drug, with peer-valuation commentary and ETF flows as secondary noise. Continuation likelihood over the next few weeks is moderate (~40–50%), since single-trial readouts often fade without confirmatory data or regulatory milestones. Informational only — not financial advice.

Any AI summary is an interpretation of public news, not advice or a price target.

AMGN Signal Score & analysis · 360head Stockiq